Novel transcript, antisense to BEGAIN (ENSG00000296402)

This entity is a non-coding RNA produced in the antisense direction relative to the BEGAIN gene, annotated as ENSG00000296402. Antisense transcripts are pervasive in mammalian genomes and often act to regulate adjacent or overlapping genes through multiple molecular mechanisms, primarily post-transcriptional and epigenetic[3][4][5]. Experimental research has shown that antisense transcription can modify chromatin near gene promoters, leading to altered rates of sense transcript production, processing, and stability[1][2]. While antisense RNAs frequently exhibit regulatory activity, there20is no evidence that this specific transcript encodes a protein or functions as a therapeutic target. It is best classified as a regulatory non-coding RNA whose biological significance may pertain to the modulation of BEGAIN gene expression or other nucleic acid-mediated phenomena. There are currently no drugs, biomarkers, or known disease associations directly related to ENSG00000296402; furthermore, it is not regarded as a molecular target for therapeutic intervention. The primary literature supports its functional role as a chromatin and gene expression regulator, but systematic functional validation and disease associations are lacking for this particular transcript[1][2][3][4][5].